T

Travere Therapeutics
D

TVTX

18.290
USD
0.06
(0.33%)
Market Open
Volume
11,389
EPS
-3
Div Yield
-
P/E
-4
Market Cap
1,592,727,745
OverviewSignalsIdeasNews
Related Instruments
    A
    AGEN
    -0.05000
    (-1.80%)
    2.72500 USD
    B
    BCRX
    -0.41500
    (-5.57%)
    7.03500 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    J
    JAZZ
    -2.620
    (-2.11%)
    121.660 USD
    K
    KALA
    0.01000
    (0.15%)
    6.87000 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    103.72 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.945 USD
    More
News

Title: Travere Therapeutics

Sector: Healthcare
Industry: Biotechnology
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.